2012 Program

Wed, 11/28

6:30 PM – 8:00 PM

Thu, 11/29

7:50 AM – 8:00 AM
Welcome and Opening Remarks
  • Margaret Anderson
    Executive Director, FasterCures
8:00 AM – 9:00 AM
PLENARY - The (Near) Future of Bioscience and Health
  • Michael Milken
    Chairman, Milken Institute; Founder, FasterCures

  • Kenneth Davis
    President and CEO, The Mount Sinai Medical Center
  • Mikael Dolsten
    President, Worldwide Research and Development, Pfizer
  • Risa Lavizzo-Mourey
    President and CEO, Robert Wood Johnson Foundation
  • Jay Schnitzer
    Director, Defense Sciences Office, Defense Advanced Research Projects Agency (DARPA)
  • Vicki Seyfert-Margolis
    Senior Advisor, Science Innovation and Policy, Office of the Commissioner, U.S. Food and Drug Administration
9:15 AM – 10:10 AM
PANEL - License to drive (innovation): IP strategies to support, not slow, progress
  • Maria Freire
    President, Foundation for the NIH

  • Joseph DeSimone
    Director, Frank Hawkins Kenan Institute of Private Enterprise, and Professor of Chemistry, University of North Carolina
  • Stephen Friend
    President, Sage Bionetworks
  • Stephen Johnson
    Partner, Kirkland & Ellis LLP
  • Teresa Stanek Rea
    Deputy Director, U.S. Patent and Trademark Office
  • Steven Tregay
    Founder, President, and CEO, FORMA Therapeutics
PANEL - Optimists only: Is life sciences still a good investment?
  • Chris Varma
    President and CEO, Blueprint Medicines

  • Jens Eckstein
    President, SR One
  • Dan Hartman
    Director, Integrated Development, Bill and Melinda Gates Foundation
  • Garen Staglin
    Co-founder, One Mind for Research
  • Alastair J.J. Wood
    Partner, Symphony Capital
PANEL - Social media changing research norms
  • Matthew Herper
    Senior Editor, Forbes Magazine

  • Jon Fredrickson
    Vice President, Government Practice, Innocentive
  • Elizabeth Iorns
    Co-Founder and CEO, Science Exchange
  • Sally Okun
    Health Data Integrity Manager, PatientsLikeMe
  • Greg Simon
    CEO, Poliwogg
  • John Wilbanks
    Senior Fellow, Ewing Marion Kauffman Foundation
9:15 AM – 11:40 AM
12:00 PM – 1:30 PM
LUNCHEON PLENARY - What you probably don't know about innovation at FDA
  • Margaret Anderson
    Executive Director, FasterCures

  • Joseph DeGeorge
    Vice President, Safety Assessment & Laboratory Animal Resources, Merck Research Laboratories
  • Frank L. Douglas
    President and CEO, Austen BioInnovation Institute
  • Richard A. Insel
    Chief Scientific Officer, JDRF
  • Jonathan Leff
    Managing Director, Warburg Pincus
  • Janet Woodcock
    Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
1:45 PM – 6:00 PM
3:45 PM – 4:40 PM
PANEL - Beyond business as usual: Disrupting the biopharma business model
  • Gautam Jaggi
    Global Lead Analyst/Editor of Beyond Borders and Progressions, Ernst & Young Global Life Sciences Center

  • Kathy Giusti
    Founder and CEO, Multiple Myeloma Research Foundation
  • Bernard Munos
    Chief Apostle, Breakthrough Innovation, InnoThink
  • Steven Marc Paul
    Director, Helen & Robert Appel Institute for Alzheimer's Research, Weill Cornell Medical College
  • Tomasz Sablinski
    Founder, Transparency Life Sciences; Head of Development, Celtic Therapeutics
  • Ben Shapiro
    Senior Partner and Chair, PureTech Ventures
PANEL - Can clinical trials be better, faster, and cheaper?
  • Melissa Stevens
    Deputy Executive Director, FasterCures

  • Robert Califf
    Professor of Cardiology, Vice Chancellor for Clinical Research, and Director of the Duke Translational Medicine Institute, Duke University School of Medicine
  • Clifford A. Hudis
    Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center; President-elect, American Society of Clinical Oncology
  • Lawrence J. Lesko
    Professor of Pharmaceutics, Director, Center for Pharmacometrics and Systems Pharmacology, University of Florida
  • Garry Neil
    Partner, Apple Tree Partners
  • Susan Solomon
    CEO and Co-Founder, New York Stem Cell Foundation
PANEL - The Health Network Trust: Improving innovation, outcomes and efficiency in healthcare
  • Dominique Pahud
    Director, Advancing Innovation, Ewing Marion Kauffman Foundation

  • John Chaffins
    Director, Product Design & Construction, Lybba
  • Richard Colletti
    Professor of Pediatrics and Vice Chair, Department of Pediatrics, University of Vermont School of Medicine
  • Anmol Madan
    Co-founder, CEO, and Data Scientist,
  • Peter Margolis
    Professor of Pediatrics and Director of Research, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine
  • John Wilbanks
    Senior Fellow, Ewing Marion Kauffman Foundation
5:00 PM – 7:30 PM

Fri, 11/30

7:00 AM – 3:00 PM
7:50 AM – 8:00 AM
8:00 AM – 9:00 AM
PLENARY - Molecule to man (and woman): Speeding translation to human trials
  • Margaret Anderson
    Executive Director, FasterCures

  • Christopher P. Austin
    Director, National Center for Advancing Translational Sciences
  • Anna Barker
    Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University
  • Dale Edgar
    Vice President, Science and Technology Partnerships, Lilly Research Laboratories
  • Stelios Papadopoulos
    Co-Founder and Chairman, Exelixis
  • Todd Sherer
    CEO, The Michael J. Fox Foundation for Parkinson's Research
9:15 AM – 10:10 AM
PANEL - He who pays, eats: The evolving role of payers in the R&D ecosystem
  • Ceci Connolly
    Managing Director, Health Research Institute, PricewaterhouseCoopers

  • Freda Lewis-Hall
    Executive Vice President, Chief Medical Officer, Pfizer Inc.
  • Shari Ling
    Deputy Chief Medical Officer, Centers for Medicare & Medicaid Services
  • Kim J. Popovits
    President and CEO, Genomic Health, Inc.
  • Russell Teagarden
    Former Vice President, Scientific Affairs, Advanced Clinical Science & Research, Medco Health Solutions, Inc.
  • Mark Tykocinski
    Dean, Jefferson Medical College
PANEL - Rules, tools, and data pools for catalyzing drug development
  • Brett Davis
    Senior Director, Health Sciences, Global Business Development and Strategy, Oracle

  • Dana Ball
    CEO and Co-Founder, T1D Exchange
  • Marc Bonnefoi
    Head, North America R&D Hub, Sanofi US
  • Carolyn Compton
    President and CEO, Critical Path Institute
  • Eric D. Perakslis
    Chief Information Officer and Chief Scientist (Informatics), U.S. Food and Drug Administration
  • George Vradenburg
    Chairman, USAgainstAlzheimer's
PANEL - Tech transfer 2.0: Innovation in university commercialization
  • Lou DeGennaro
    Chief Mission Officer, Leukemia and Lymphoma Society

  • Louis Berneman
    Founding Partner, Osage University Partners
  • Jodi Black
    Deputy Director, Division of Extramural Research Activities, National Heart Lung and Blood Institute, National Institutes of Health
  • Chris Coburn
    Executive Director, Cleveland Clinic Innovations
  • Regis B. Kelly
    Director, The California Institute for Quantitative Biosciences (QB3), University of California
  • Robert Urban
    Head, Cambridge Innovation Center, Johnson & Johnson
11:45 AM – 12:40 PM
PANEL - Basic science: The more we know, the more we know what we don't know
  • Cecilia Arradaza
    Director, Communications & Marketing, FasterCures

  • William Chin
    Executive Dean for Research, Harvard Medical School
  • Thomas R. Insel
    Director, National Institute of Mental Health, National Institutes of Health
  • Brian Mansfield
    Deputy Chief Research Officer, Foundation Fighting Blindness
  • Matthias von Herrath
    Director, Type 1 Diabetes Research and Development (R&D) Center, Novo Nordisk
PANEL - Election 2012: What does it mean for medical research?
  • Greg Simon
    CEO, Poliwogg

  • Scott Gottlieb
    Resident Fellow, American Enterprise Institute
  • Cheryl Jaeger
    Senior Policy Advisor, Majority House Leadership, U.S. House of Representatives
  • Wendell Primus
    Senior Health Policy Advisor, Minority House Leadership, U.S. House of Representatives
  • Neera Tanden
    President and CEO, Center for American Progress; Counselor, Center for American Progress Action Fund
PANEL - Molecular diagnostics: Turning on the lights
  • Wendy Selig
    President and CEO, Melanoma Research Alliance

  • Alberto Gutierrez
    Director, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration
  • David Parkinson
    Venture Partner, New Enterprise Associates
  • Michael Pellini
    President and CEO, Foundation Medicine
  • Jeffrey Trent
    President and Research Director, The Translational Genomics Research Institute
  • Sean Tunis
    President and CEO, Center for Medical Technology Policy
1:00 PM – 2:30 PM
LUNCHEON PLENARY - Powered by patients
  • Susan Dentzer
    Editor-in-Chief, Health Affairs

  • Bonnie J. Addario
    Founder & Chair, President, The Bonnie J. Addario Lung Cancer Foundation
  • N. Anthony Coles
    President, CEO, and Member of the Board, Onyx Pharmaceuticals
  • Francis Collins
    Director, National Institutes of Health
  • Scott Johnson
    President, CEO, and Founder, Myelin Repair Foundation
  • Dennis Urbaniak
    Vice President, U.S. Diabetes, Sanofi
2:45 PM – 4:40 PM